Semaglutide Weekly Injection Active Ingredient in Ozempic and Wegovy 15% Body Weight Reduction GLP-1 Receptor Agonist FDA Approved for Type 2 Diabetes (2017) and Weight Loss (2021) Most Common Side Effects: Nausea, Diarrhea, Vomiting, Constipation, Indigestion, and Abdominal Pain Tirzepatide Weekly Injection Active Ingredient in Mounjaro 20% Body Weight reduction Dual GLP-1 and GIP Receptor Agonist FDA Approved for Type 2 Diabetes (2022) and on Fast-track for Weight Loss Approval in 2023 Most Common Side Effects: Nausea, Diarrhea, Vomiting, Constipation, Indigestion, and Abdominal Pain These injections are GLP-1 medications that have been FDA-approved for Type 2 diabetes because of their ability to lower blood sugar and raise insulin levels
Commercial GHK-Cu serums typically claim 6-12 month shelf life unopened when properly formulated with preservatives and appropriate pH, dropping to 3-6 months after opening due to air exposure and contamination introduction
& Akillioglu, K
Legal Status Approved Unknown Approved Unknown Classification Category Hepatoprotective Agent, Dietary supplement, Antioxidants, Antidotes Loading related questions
Does constipation mean the intestines are paralyzed
